Form 4 for RPID RAPID MICRO BIOSYSTEMS, INC.
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-09 · accession 0001104659-21-115207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-09-13 | 2021-09-09 | RPID | Kollender Richard S | Dir | X - OptEx | $0.05 | +107.8K | 1.48M | +8% | +$5,391 |
| DMI | 2021-09-13 | 2021-09-09 | RPID | Kollender Richard S | Dir | X - OptEx | $0.00 | -107.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-09-09 | X | A | 107,816 | $0.05 | 1,481,009 | I Held by Quaker Bioventures II, L.P. | — | — | (F1) These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is an executive manager of Quaker Bioventures Capital II, LLC, the general partner of Quaker Bioventures Capital II, L.P, the general partner of Quaker Bioventures II, LP, and may be deemed to beneficially hold the shares but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. |
| 2 | Derivative | Series B1 Warrant (right to buy) | 2021-09-09 | X | D | 12,903 | $0.00 | 0 | I Held by Quaker Bioventures II, L.P. | $0.05 · — to 2027-12-06 | 12,903 Class A Common Stock | (F1) These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is an executive manager of Quaker Bioventures Capital II, LLC, the general partner of Quaker Bioventures Capital II, L.P, the general partner of Quaker Bioventures II, LP, and may be deemed to beneficially hold the shares but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. (F2) Immediately exercisable. |
| 3 | Derivative | Series A1 Warrant (right to buy) | 2021-09-09 | X | D | 82,010 | $0.00 | 0 | I Held by Quaker Bioventures II, L.P. | $0.05 · — to 2027-07-24 | 82,010 Class A Common Stock | (F1) These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is an executive manager of Quaker Bioventures Capital II, LLC, the general partner of Quaker Bioventures Capital II, L.P, the general partner of Quaker Bioventures II, LP, and may be deemed to beneficially hold the shares but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. (F2) Immediately exercisable. |
| 4 | Derivative | Series B1 Warrant (right to buy) | 2021-09-09 | X | D | 12,903 | $0.00 | 0 | I Held by Quaker Bioventures II, L.P. | $0.05 · — to 2028-01-17 | 12,903 Class A Common Stock | (F1) These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is an executive manager of Quaker Bioventures Capital II, LLC, the general partner of Quaker Bioventures Capital II, L.P, the general partner of Quaker Bioventures II, LP, and may be deemed to beneficially hold the shares but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. (F2) Immediately exercisable. |